Sen0014196 (high dose)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
8Huntington disease1

8. Huntington disease    [ 197 clinical trials,   171 drugs,   (DrugBank: 54 drugs),   82 drug target genes,   144 drug target pathways]
Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 197 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01485952
(ClinicalTrials.gov)
March 201129/11/2011An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients to Assess Pharmacokinetics, Candidate Pharmacodynamic Measures of Target Engagement and Disease Modulation as Well as Acute Phenotypical Effects Following Multiple Oral Doses of SEN0014196.Huntington DiseaseDrug: SEN0014196 (Low Dose);Drug: SEN0014196 (High Dose);Drug: PlaceboSiena Biotech S.p.A.Seventh Framework Programme;European Huntington's Disease NetworkCompleted18 Years70 YearsBoth55Phase 1Germany